131 related articles for article (PubMed ID: 6222471)
21. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
Melamed J; Medicus RG; Arnaout MA; Colten HR
J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
[TBL] [Abstract][Full Text] [Related]
22. Binding of fluid-phase complement components C3 and C3b to human lymphocytes.
Sim E; Sim RB
Biochem J; 1981 Sep; 198(3):509-18. PubMed ID: 7326019
[TBL] [Abstract][Full Text] [Related]
23. Demonstration of C3b receptor-like activity and of decay-accelerating factor-like activity on rabbit erythrocytes.
Horstmann RD; Müller-Eberhard HJ
Eur J Immunol; 1986 Sep; 16(9):1069-73. PubMed ID: 2428623
[TBL] [Abstract][Full Text] [Related]
24. Complement components on human lymphocytes.
Wilson AB; Prichard-Thomas S; Gurner BW; Lachmann PJ; Coombs RR
Clin Immunol Immunopathol; 1982 Jan; 22(1):118-27. PubMed ID: 6214346
[No Abstract] [Full Text] [Related]
25. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
Nilsson-Ekdahl K; Nilsson B
Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
[TBL] [Abstract][Full Text] [Related]
26. Complement fragments C3b and iC3b coupled to latex induce a respiratory burst in human neutrophils.
Hoogerwerf M; Weening RS; Hack CE; Roos D
Mol Immunol; 1990 Feb; 27(2):159-67. PubMed ID: 2138709
[TBL] [Abstract][Full Text] [Related]
27. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the lymphocyte membrane receptor for factor H (beta 1H-globulin) with an antibody to anti-factor H idiotype.
Lambris JD; Ross GD
J Exp Med; 1982 May; 155(5):1400-11. PubMed ID: 6461713
[TBL] [Abstract][Full Text] [Related]
29. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides.
Lambris JD; Avila D; Becherer JD; Müller-Eberhard HJ
J Biol Chem; 1988 Aug; 263(24):12147-50. PubMed ID: 2969896
[TBL] [Abstract][Full Text] [Related]
30. Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.
Pangburn MK; Schreiber RD; Trombold JS; Müller-Eberhard HJ
J Exp Med; 1983 Jun; 157(6):1971-80. PubMed ID: 6222136
[TBL] [Abstract][Full Text] [Related]
31. Effect of trypsinization on the activity of human factor H.
Hong K; Kinoshita T; Dohi Y; Inoue K
J Immunol; 1982 Aug; 129(2):647-52. PubMed ID: 6211491
[No Abstract] [Full Text] [Related]
32. Regulatory system of guinea-pig complement C3b: tests for compatibility of guinea-pig factors H and I with human factors.
Seya T; Okada M; Hazeki K; Nagasawa S
Mol Immunol; 1991; 28(4-5):375-82. PubMed ID: 1829503
[TBL] [Abstract][Full Text] [Related]
33. [Immune adherence (C3b) receptor activity of erythrocytes in patients with esophageal cancer and cancer of the gastric cardia].
Cai FQ; Jing YH; Gao YF; Yang XW; Li FZ; Zhao LQ; Xiong ML
Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):253-5. PubMed ID: 2944730
[TBL] [Abstract][Full Text] [Related]
34. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
[TBL] [Abstract][Full Text] [Related]
35. The human C3b receptor.
Cook J; Kazatchkine M
Nouv Rev Fr Hematol (1978); 1983; 25(5):297-301. PubMed ID: 6228780
[TBL] [Abstract][Full Text] [Related]
36. C3 cleaved by membrane proteases binds to C3b acceptors expressed on concanavalin A-stimulated human lymphocytes and enhances antibody-dependent cellular cytotoxicity.
Erdei A; Benczur M; Fábry Z; Dierich MP; Gergely J
Scand J Immunol; 1984 Aug; 20(2):125-31. PubMed ID: 6236547
[TBL] [Abstract][Full Text] [Related]
37. Human monocyte recognition of complement-coated lymphoblastoid cells.
Armstrong S; McDermott P; Schreiber AD
J Leukoc Biol; 1985 Feb; 37(2):161-74. PubMed ID: 3881547
[TBL] [Abstract][Full Text] [Related]
38. Control of the immune complex-complement interaction by protein H of the alternative complement pathway and the natural inhibitor heparin.
Spycher MO; Nydegger UE
Eur J Immunol; 1984 Mar; 14(3):276-9. PubMed ID: 6231187
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3.
Bartók I; Walport MJ
J Immunol; 1995 May; 154(10):5367-75. PubMed ID: 7730637
[TBL] [Abstract][Full Text] [Related]
40. Interaction of human monocytes, macrophages, and polymorphonuclear leukocytes with zymosan in vitro. Role of type 3 complement receptors and macrophage-derived complement.
Ezekowitz RA; Sim RB; MacPherson GG; Gordon S
J Clin Invest; 1985 Dec; 76(6):2368-76. PubMed ID: 2934410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
